DMW - Deutsche Medizinische Wochenschrift, Inhaltsverzeichnis Dtsch Med Wochenschr 2006; 131(20): 1173-1175DOI: 10.1055/s-2006-941746 Kommentar | Commentary Diabetologie, Epidemiologie © Georg Thieme Verlag KG Stuttgart · New York Diabetische Retinopathie und Makulopathie Diabetic retinopathy and maculopathyH.-P Hammes1 , K.-D Lemmen2 , C. Jochmann3 , P. Wiedemann3 15. Medizinische Klinik des Klinikum Mannheim 2Augenklinik des St. Martinus-Krankenhauses Düsseldorf 3Klinik und Poliklinik für Augenheilkunde des Universitätsklinikums Leipzig AöR Artikel empfehlen Abstract Artikel einzeln kaufen Schlüsselwörter diabetische Retinopathie - Makulopathie - Früherkennung Key words diabetic retinopathy - maculopathy - screening Volltext Referenzen Literatur 1 Degenring R F, Kreissig I, Jonas B J. Intraokulare Triamcinolongabe bei diffusem diabetischen Makulaödem. Ophthalmologe. 2004; 101 251-254 2 Diabetic Retinopathy Vitrectomy Study Research Group . Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5. Arch Ophthalmol. 1990; 108 958-964 3 Dillinger P, Mester U. Vitrectomy with removal of the internal limiting membane in chronic diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol. 2004; 242 630-637 4 Early Treatment Diabetic Retinopathy Study (ETDRS) Group . Results and summary. Ophthalmology. 1991; (Suppl 5) 98 739-840 5 Frank R N. Diabetic retinopathy. N Engl J Med. 2004; 350 48-58 6 Gaede P, Vedel P, Larsen N, Jensen G V, Parving H H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348 383-393 7 Hörle S, Gruner F, Kroll P. Epidemiologie diabetischer Erblindungen- eine Übersicht. Klin Monatsbl Augenheilkd. 2002; 219 777-784 8 Jonas B J, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophhthalmol. 2001; 132 425-427 9 Klein R, Klein B E, Moss S E, Cruickshanks K J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology. 2000; 102 7-16 10 Lang G E. Medikamentöse Therapie der diabetischen Retinopathie. Ophthalmologe. 2004; 101 1165-1170 11 Lenfant C. Shattuck lecture: clinical research to clinical practice - lost in translation?. N Engl J Med. 2003; 349 868-874 12 Malone J I, Morrison A D, Pavan P R, Cuthbertson D D. Diabetic Control and Complications Trial. Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years’ duration screened for the diabetes control and complications trial. Diabetes Care. 2001; 24 522-526 13 Microvascular and acute complications in IDDM patients: the EURODIAB Complications Study. Diabetologia. 1994; 37 278-285 14 UKPDS Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352 837-853 15 van Hecke M V, Dekker J M, Stehouwer C D, Polak B C, Fuller J H, Sjolie A K, Kofinis A, Rottiers R, Porta M, Chaturvedi N. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care. 2005; 28 1383-1389 16 von Stackelberg J -M. AOK im Dialog, DMP - Höhere Versorgungsqualität für chronisch Kranke. Frankfurt, KomPart Verlagsgesellschaft mbH & Co KG 2005: 31-37 Prof. Dr. H.-P. Hammes 5. Medizinische Klinik Klinikum Mannheim Theodor-Kutzer-Ufer 1-3 68167 Mannheim eMail: hans-peter.hammes@med5.ma.uni-heidelberg.de
